Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma

BACKGROUND: Definitive chemoradiotherapy (CRT) is standard of care for nasopharyngeal carcinoma. Due to the tumor localization and concomitant platinum-based chemotherapy, hearing impairment is a frequent complication, without defined dose-threshold. In this study, we aimed to achieve the maximum po...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamaj, Enkelejda, Vu, Erwin, van Timmeren, Janita E., Leonardi, Chiara, Marc, Louise, Pytko, Izabela, Guckenberger, Matthias, Balermpas, Panagiotis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017833/
https://www.ncbi.nlm.nih.gov/pubmed/33794949
http://dx.doi.org/10.1186/s13014-021-01796-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017833/
https://www.ncbi.nlm.nih.gov/pubmed/33794949
http://dx.doi.org/10.1186/s13014-021-01796-4

Ejemplares similares